Endocrinology Research and Practice
Review Article

Subclinical Autonomous Glucocorticoid Hypersecretion

1.

Ankara University, School of Medicine, Department of Internal Medicine, Ankara, Turkey

2.

Ankara University, School of Medicine, Department of Endocrinology and Metabolic Diseases, Ankara, Turkey

Endocrinol Res Pract 2006; 10: 29-33
Read: 1436 Downloads: 476 Published: 01 June 2006

Abstract

Subclinical autonomous glucocorticoid hypersecretion (SAGH) occurs in patients who have clinically nonfunctioning adrenal adenomas when cortisol secretion becomes autonomous and dysregulated, not fully restrained by pituitary feedback. Up to 20 percent of patients with adrenal incidentalomas have some form of
subclinical hormonal dysfunction and may represent a population at higher risk for metabolic disorders and cardiovascular disease. In most cases the degree of hypercortisolism is only slightly elevated than the physiologic daily production rate of cortisol. Dexamethasone suppression tests (DSTs) were employed extensively to screen for subclinical hypercortisolism in patients who have adrenal incidentaloma. Although adrenalectomy has been demonstrated to correct the biochemical abnormalities, its effect on long-term outcome and quality of life is unknown.
 

Files
EISSN 2822-6135